Medicinal Products

Lynparza

Name Lynparza
Active Substance olaparib
Prescription na recept
Type of prescription ograničeni recept
Distribution u ljekarni
ATC Code L01
Medicinal product marketed in the Croatia Da

Note

The medicinal product has been authorised via centralised procedure in all Member States of the European Union based on the European Medicines Agency's expert opinion. Additional information on the medicinal product can be found under the following link:https://www.ema.europa.eu/en/medicines/human/EPAR/lynparza

The marketing authorisation has been granted by the European Commission. All marketing authorisations of the European Commission can be found under the following link: http://ec.europa.eu/health/documents/community-register/html/index_en.htm

Direct Healthcare Professional Communication

Name Date Download
Pismo zdravstvenim radnicima o riziku od medikacijskih pogrešaka zbog uvođenja novog farmaceutskog oblika lijeka Lynparza (olaparib) 29.11.2018 AstraZeneca d.o.o.
Back